Cyclin E and p53 in Renal Pelvic and Ureteral Cancer
Author Information
Author(s): M Furihata, Y Ohtsuki, H Sonobe, T Shuin, A Yamamoto, N Terao, M Kuwahara
Primary Institution: Kochi Medical School
Hypothesis
The study investigates the prognostic significance of cyclin E and p53 protein overexpression in transitional cell carcinoma of the renal pelvis and ureter.
Conclusion
The simultaneous overexpression of cyclin E and p53 is associated with poorer prognosis in patients with transitional cell carcinoma.
Supporting Evidence
- 29.8% of tumors showed positive immunoreaction with cyclin E antibody.
- 28.9% of tumors showed positive immunoreaction with p53 antibody.
- 69.4% of cyclin E-positive tumors also exhibited positive p53 staining.
- Patients with TCCs coexpressing cyclin E and p53 had significantly poorer prognosis.
Takeaway
This study found that when both cyclin E and p53 proteins are overexpressed in kidney cancer, patients tend to have worse outcomes.
Methodology
Immunohistochemical examination of cyclin E and p53 protein expression in tumor samples from 121 patients.
Limitations
The study is limited to a specific cohort and may not generalize to all populations.
Participant Demographics
121 patients, 84 men and 37 women, ages 45-93 years (mean age 71.4 years).
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website